第 1 到 20 筆結果,共 20 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2021 | Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 | KUEI-PIN CHUNG ; YEN-LIN HUANG ; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang ; Nakahira, Kiichi; Huang, Yen-Tsung; MONG-WEI LIN ; SHANG-GIN WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | Molecular Oncology | 10 | 8 | |
2 | 2019 | Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer | Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU ; Chang T.-H.; TZU-HSIU TSAI ; Gow C.-H.; YIH-LEONG CHANG ; JIN-YUAN SHIH | International Journal of Cancer | 34 | 34 | |
3 | 2019 | IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer | SHANG-GIN WU ; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU ; YIH-LEONG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH | Cancers | 15 | 12 | |
4 | 2017 | Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | ERJ open research | 34 | 0 | |
5 | 2017 | Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C | Chang, Tzu-Hua; Tsai M.-F.; Gow, Chien-Hung; SHANG-GIN WU ; Liu, Yi-Nan; YIH-LEONG CHANG ; SUNG-LIANG YU ; HSING-CHEN TSAI ; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; PAN-CHYR YANG ; JIN-YUAN SHIH | Cancer letters | 48 | 47 | |
6 | 2016 | The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients | SHANG-GIN WU ; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; CHIH-HSIN YANG ; Wen Y.-F.; JIN-YUAN SHIH | Oncotarget | 207 | 191 | |
7 | 2016 | Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 63 | 51 | |
8 | 2016 | The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 32 | 28 | |
9 | 2014 | Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case | Gow C.-H.; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH | Medical Oncology | 24 | 21 | |
10 | 2014 | Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 69 | 64 | |
11 | 2013 | Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | SHANG-GIN WU ; Hu F.-C.; YIH-LEONG CHANG ; Lee Y.-C.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Wu J.-Y.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 35 | 36 | |
12 | 2012 | EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR | SHANG-GIN WU ; YAO-WEN KUO ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 90 | 72 | |
13 | 2012 | Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma | TZU-HSIU TSAI ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHEN-TU WU ; Tsai M.-F.; Wei P.-F.; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 22 | 26 | |
14 | 2012 | RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer | TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 42 | 37 | |
15 | 2011 | Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; YEUN-CHUNG CHANG ; Hsu Y.-C.; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 69 | 61 | |
16 | 2011 | Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction | SHANG-GIN WU ; YIH-LEONG CHANG ; JOU-WEI LIN ; CHEN-TU WU ; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; CHONG-JEN YU ; JIN-YUAN SHIH | PloS one | 49 | 43 | |
17 | 2011 | Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations | SHANG-GIN WU ; CHIH-HSIN YANG ; CHONG-JEN YU ; JIH-HSIANG LEE ; Hsu Y.-C.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 41 | 35 | |
18 | 2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
19 | 2008 | Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; Gow C.-H.; YIH-LEONG CHANG ; CHONG-JEN YU ; Shin J.-Y.; PAN-CHYR YANG | Clinical Cancer Research | 278 | 250 | |
20 | 2008 | Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern | SHANG-GIN WU ; YIH-LEONG CHANG ; Hsu Y.-C.; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Tsai M.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Oncologist | 73 | 67 |